Sign in
Taking peopleNo phase

Targeted Temperature Management Via Bladder Monitoring in ICH

Key facts

Who runs it
Yanyan Gong
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
318 people, planned
Started
15 Mar 2026
Expected to end
30 Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Bladder Temperature Monitoring
  • Standard Temperature Monitoring Group
Record updated
10 June 2026

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Neurocritical care patients: Study subjects are patients with first-time spontaneous intracerebral hemorrhage
  • Age ≥ 18 years and ≤ 85 years
  • Glasgow Coma Scale (GCS) score ≤ 8 at ICU admission
  • For supratentorial ICH: Hematoma volume < 60 mL. For subarachnoid hemorrhage (SAH): Modified Fisher grade ≥ 2, and the aneurysm has been treated with endovascular intervention
  • Pre-morbid modified Rankin Scale (mRS) score of 0 or 1
  • Signed informed consent provided by a legally authorized representative

Who cannot take part

  • Fever (≥38.0°C) that lasted over 1 hour or occurred more than once prior to enrollment
  • Underlying conditions with a life expectancy of less than 6 months, estimated prior to onset
  • Severe injury indicative of poor prognosis: brain death, receiving palliative care only, or irreversible brain injury
  • Currently participating in other investigational/interventional clinical trials (involving medical devices or drugs)
  • Pre-existing neurological, psychiatric, or other comorbidities that may compromise the assessment of neurological or functional outcomes
  • Pregnancy
  • Unilateral or bilateral pupillary dilation
  • Subjects deemed ineligible for enrollment by the investigator

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn whether a bladder temperature monitoring-guided targeted temperature management (TTM) strategy improves functional recovery in patients with severe intracerebral hemorrhage, compared to conventional temperature monitoring. It will also assess the safety of this monitoring approach. The main questions it aims to answer are:

Read full original descriptionShow less

* Does continuous bladder temperature monitoring-guided TTM improve the likelihood of a favorable functional outcome (modified Rankin Scale score 0-2) at 180 days after onset? * What medical problems (such as infections, shivering, deep vein thrombosis, or sepsis) do participants experience while under the TTM strategy? Researchers will compare the intervention group (using continuous bladder temperature monitoring) with the control group (using conventional intermittent temperature monitoring with a mercury thermometer at the armpit) to see if the bladder temperature-guided TTM strategy leads to better outcomes.

Participants will:

* Be randomly assigned to one of the two temperature monitoring strategies * Receive standard medical and surgical care for severe intracerebral hemorrhage

The 2 groups in the trial

  • Bladder Temperature Monitoring GroupTreatment being tested

    Patients in this arm will receive Targeted Temperature Management (TTM) guided by continuous, real-time core temperature monitoring via a bladder thermometer. TTM may include therapeutic hypothermia (TH, 32.0°C ≤ temp \< 36.0°C), normothermia control (36.0-37.5°C), or fever treatment, as clinically indicated. Temperature is recorded hourly.

    Treatment: Bladder Temperature Monitoring

  • Standard Temperature Monitoring GroupExisting treatment, for comparison

    Patients in the control arm will receive Targeted Temperature Management (TTM) guided by intermittent axillary temperature measurements using a mercury-in-glass thermometer, recorded every four hours. TTM may include therapeutic hypothermia, maintenance of normothermia, or treatment of fever, as clinically indicated.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Efficacy of Bladder Temperature Monitoring-Guided Targeted Temperature Management in Patients With Severe : A Multicenter Randomized Controlled Trial
Criteria questions
Built from NCT07302009, who can take part
Record updated
10 June 2026